Opus Genetics, Inc. (IRD) earnings
IRD earnings moved a median of 0.00% by the close. Quarterly and annual IRD reports and results, each read against the price at its own news timestamp. Back to the IRD overview →
10 measured IRD earnings events.
Where these IRD earnings landedvs 10 measured IRD earnings reactions
| Middle 50% of IRD earnings reactions | -1.70% to +2.44% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 IRD earnings events with a measured close landed between -1.70% and +2.44%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Opus Genetics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.88% | |
| Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update | Press release | +0.53% | -2.36% | |
| Form 10-Q Opus Genetics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.15% | -1.18% | |
| Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update | Press release | +1.19% | +2.98% | |
| Form 10-K Opus Genetics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.31% | +2.65% | |
| Form 10-Q Opus Genetics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.52% | +0.00% | |
| Opus Genetics Announces Financial Results for Third Quarter 2025 and Provides Corporate Update | Press release | -0.52% | +0.00% | |
| Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update | Press release | +0.19% | +12.38% | |
| Opus Genetics Announces Financial Results for First Quarter 2025 and Provides Corporate Update | Press release | +1.07% | -2.96% | |
| Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update | Press release | +0.90% | +1.79% |
Keep exploring
More IRD: analyst actions → · SEC filings → · IRD overview →